| Literature DB >> 32232189 |
Manicka Saravanan Subramanian1, Vishwajeet Singh2, Prashun Chatterjee1, Sada Nand Dwivedi2, Aparajit Ballav Dey1.
Abstract
BACKGROUND: Falls are one of the major causes of disability in older people. A wide range of risk factors for falls are described according to setting - inpatient, nursing homes and community. The aim of this study was to identify the risk factors for falls in an outpatient setting.Entities:
Keywords: fall risk; falls; falls screening; older people
Year: 2020 PMID: 32232189 PMCID: PMC7099749 DOI: 10.1002/agm2.12096
Source DB: PubMed Journal: Aging Med (Milton) ISSN: 2475-0360
Demographic variables and health status of the study population
| Variables | Non fallers (N = 122) | Fallers (N = 38) |
|
|
|---|---|---|---|---|
| Age | ||||
| Mean (SD) | 74.75 (7.07) | 74.47 (8.94) | 0.19 | .84 |
| Sex | ||||
| Males | 98 (80.33%) | 28 (73.68%) | 0.76 | .38 |
| Females | 24 (19.67%) | 10 (26.31%) | ||
| Education | ||||
| Illiterate | 18 (14.75%) | 7 (18.42%) | 0.30 | .59 |
| School education and above | 104 (85.25%) | 31 (81.58%) | ||
| Socioeconomic class | ||||
| Upper class | 37 (30.33%) | 9 (23.68%) | 3.61 | .17 |
| Middle class | 71 (58.20%) | 20 (52.64%) | ||
| Lower class | 14 (11.47%) | 9 (23.68%) | ||
| Caregiver status | ||||
| Living alone and widowers | 22 (18.03%) | 13 (34.21%) | 4.44 | .03 |
| Joint family | 100 (81.97%) | 25 (65.79%) | ||
| Financial status | ||||
| Dependent | 55 (45.08%) | 17 (44.74%) | 3.24 | .20 |
| Independent – self‐ employed | 6 (4.92%) | 5 (13.16%) | ||
| Independent – pensioners | 61 (50%) | 16 (42.11%) | ||
| Alcohol use | 25 (20.49%) | 8 (21.05%) | 0.63 | .73 |
| Smoking status | ||||
| Never a smoker | 94 (77.05%) | 27 (71.05%) | 1.58 | .43 |
| Former smoker | 24 (19.67%) | 8 (21.05%) | ||
| Smoker | 4 (3.28%) | 3 (7.89%) | ||
| Body mass index | ||||
| Mean (SD) | 23.51 (4.30) | 22.46 (4.52) | 1.29 | .20 |
| Fear of falling | 67 (54.92%) | 30 (78.95%) | 7.01 | .01 |
| Diabetes | 21 (17.21%) | 10 (26.32%) | 1.53 | .21 |
| Hypertension | 66 (54.10%) | 20 (52.63%) | 0.02 | .87 |
| Joint pain | 56 (45.90%) | 19 (50%) | 0.19 | .66 |
| Coronary artery disease | 16 (13.11%) | 8 (21.05%) | 1.43 | .23 |
| Cerebrovascular diseases | 7 (5.74%) | 2 (5.26%) | 0.01 | >.99 |
| Vision impairment (Cataract/glaucoma/refractory errors) | 36 (29.51%) | 17 (44.74%) | 3.03 | .08 |
| Malignancies | 3 (2.46%) | 1 (2.63%) | 0.00 | >.99 |
| Benign prostatic hypertrophy | 28 (22.95%) | 6 (15.79%) | 0.89 | .35 |
| Hypothyroidism | 7 (5.74%) | 1 (2.63%) | 0.59 | .68 |
| Respiratory diseases | 13 (10.66%) | 2 (5.26%) | 0.99 | .52 |
| Urinary incontinence | 6 (4.92%) | 3 (7.89%) | 0.48 | .44 |
| Total no of comorbidities | ||||
| Mean (SD) | 2.36 (1.21) | 2.74 (1.11) | −1.67 | .09 |
| Calcium channel blockers | 43 (35.25%) | 11 (28.95%) | 0.51 | .47 |
| Angiotensin receptor blockers | 38 (31.15%) | 11 (28.95%) | 0.07 | .80 |
| ACEi | 3 (2.46%) | 2 (5.26%) | 0.75 | .59 |
| Diuretics | 23 (18.85%) | 2 (5.26%) | 4.06 | .04 |
| Alpha blockers | 27 (22.13%) | 6 (15.79%) | 0.71 | .40 |
| Anti‐histamines | 8 (6.56%) | 1 (2.63%) | 0.84 | .69 |
| Beta‐blockers | 24 (19.67%) | 8 (21.05%) | 0.03 | .85 |
| Thyroxine | 8 (6.56%) | 2 (5.26%) | 0.08 | >.99 |
| Oral hypoglycemic agents | 21 (17.21%) | 10 (26.32%) | 1.54 | .21 |
| Insulin | 3 (2.46%) | 0 (0%) | 0.95 | >.99 |
| Antiplatelet agents | 29 (23.77%) | 13 (34.21%) | 1.63 | .20 |
| Anti‐anginal medications | 3 (2.46%) | 3 (7.89%) | 2.37 | .15 |
| Statins | 29 (23.77%) | 11 (28.95%) | 0.41 | .52 |
| PPI/prokinetics/laxatives | 67 (54.92%) | 22 (57.89%) | 0.10 | .74 |
| Nutritional supplements | 69 (56.56%) | 21 (55.26%) | 0.02 | .89 |
| Opioids | 33 (27.05%) | 21 (55.26%) | 10.31 | <.01 |
| Non‐opioid analgesics | 41 (33.61%) | 16 (42.11) | 0.91 | .34 |
| Neuropathic medications | 4 (3.28%) | 5 (13.16%) | 5.32 | .03 |
| Bronchodilators | 17 (13.93%) | 1 (2.63%) | 3.70 | .07 |
| Antidepressants | 15 (12.30%) | 2 (5.26%) | 1.51 | .36 |
| Anxiolytics | 1 (0.82%) | 1 (2.63%) | 0.77 | .42 |
| Benzodiazepines | 6 (4.92%) | 0 (0%) | 1.94 | .34 |
| No of medications | ||||
| Mean (SD) | 4.92 (2.20) | 5.13 (2.65) | −0.50 | .62 |
| Polypharmacy | 68 (55.74%) | 19 (50.00%) | 0.38 | .53 |
| Orthostatic hypotension | 17 (13.93%) | 4 (10.53%) | 0.29 | .78 |
| Frailty index | ||||
| Mean (SD) | 0.22 (0.10) | 0.27 (0.11) | −2.76 | .01 |
| Frail | 53 (43.44%) | 24 (63.16%) | 4.80 | .09 |
| ADL | ||||
| Mean (SD) | 19.55 (1.27) | 19.34 (1.34) | 0.86 | .39 |
| ADL impairment | 32 (26.22%) | 11 (28.94%) | 1.54 | .43 |
| IADL | ||||
| Mean (SD) | 0.28 (0.50) | 0.31 (0.52) | −0.39 | .69 |
| IADL impairment | 47 (38.52%) | 21 (55.26%) | 3.32 | .09 |
| Fall risk POMA | ||||
| Total score mean (SD) | 19.77 (3.81) | 18.89 (3.88) | 1.32 | .22 |
| Low fall risk | 17 (13.93%) | 5 (14.16%) | ||
| Medium fall risk | 67 (54.92%) | 15 (39.47%) | 3.53 | .17 |
| High fall risk | 38 (31.15%) | 18 (47.37%) | ||
| TUG score (s) Mean (SD) | 13.69 (3.90) | 14.66 (4.67) | −1.28 | .20 |
| MoCA | ||||
| Total score mean (SD) | 21.63 (4.76) | 20.50 (5.47) | 1.23 | .22 |
| Mild cognitive impairment | 51 (41.80%) | 16 (42.11%) | ||
| Dementia | 25 (20.49%) | 11 (28.95%) | 1.54 | .46 |
| GDS | ||||
| Mean (SD) | 3.65 (2.76) | 4.13 (3.21) | −0.89 | .37 |
| Depressed | 35 (35.68%) | 14 (36.84%) | 7.80 | .09 |
| Nutritional assessment | ||||
| MNA‐SF | ||||
| Total score Mean (SD) | 10.74 (2.37) | 9.47 (2.91) | 2.72 | .01 |
| At risk of malnutrition | 49 (40.16%) | 11 (28.95%) | ||
| Malnourished | 60 (49.18%) | 20 (52.63%) | 2.43 | .29 |
Abbreviations: ACEi, Angiotensin Converting Enzyme Inhibitors; ADL, Activity‐Dependent Daily Living; GDS, Geriatric Depression scale; IADL, Instrumental Activity‐Dependent Daily Living; MNA‐SF, Mini nutritional assessment short form; MoCA, Montreal cognitive assessment; POMA, performance‐oriented mobility assessment; PPI, Proton Pump Inhibitors; SD, Standard Deviation; TUG, Timed up and Go test.
Predictive model of falls from multivariable logistic regression analysis
| Variable |
| OR (95% CI) |
|---|---|---|
| Opioids | 3.40 | 5.24 (2.018‐13.611) |
| Anti‐anginal medications | 1.96 | 8.90 (0.997‐79.564) |
| Fear of falling | 2.26 | 3.17 (1.167‐08.629) |
| Vision impairment (cataract/glaucoma/refractive errors) | 2.06 | 2.71 (1.050‐07.011) |
| IADL impairment | 2.40 | 3.41 (1.251‐09.301) |
| MNA‐SF score | −2.24 | 0.82 (0.688‐00.976) |
| Independent living – pension schemes | 0.13 | 1.06 (0.413‐02.736) |
| Independent living – self‐employed | 2.03 | 5.37 (1.058‐27.329) |
| Caregiver status | −2.78 | 0.46 (0.275‐00.801) |
Abbreviations: IADL, Instrumental Activity‐Dependent Daily Living; MNA‐SF, Mini Nutritional Assessment Short Form; OR, Odds Ratio.
Figure 1Area under the curve for the predictive model. Figure shows discrimination ability of the predictive model, ROC, Receptor operator curve